Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project title: NHS National Framework for the supply of Pomalidomide commencing 1 April 2025
Offer reference number: CM/TNS/24/5719
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/24/5719/01 - Pomalidomide
Lot 1 CESW: 01/04/2025 to 31/05/2026
Lot 2 LSNE: 01/04/2025 to 31/05/2026
Lot 3 NWLN: 01/04/2025 to 31/05/2026
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Amarox Limited | 10997632 | ~£17,087,000 estimated from lot values | - |
| Grindeks Kalceks UK Ltd | 14499215 | ~£17,087,000 estimated from lot values | - |
| Thornton and Ross Ltd | 00185947 | ~£17,087,000 estimated from lot values | - |
| Wockhardt UK Limited | 05835570 | ~£17,087,000 estimated from lot values | - |
| Zentiva Pharma UK Ltd | 02158996 | ~£17,087,000 estimated from lot values | - |
Government spending data: These suppliers have received £27,137,589 in 181 payments (over £25k) from Department of Health and Social Care, NHS England (2010-04-28 to 2026-03-12).